Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$278M |
| 2 |
Exxon Mobil
XOM
|
+$270M |
| 3 |
Verizon
VZ
|
+$141M |
| 4 |
Yum China
YUMC
|
+$135M |
| 5 |
Chevron
CVX
|
+$122M |
Top Sells
Sector Composition
| 1 | Financials | 17.74% |
| 2 | Technology | 15.29% |
| 3 | Industrials | 12.37% |
| 4 | Healthcare | 11.81% |
| 5 | Consumer Discretionary | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Repare Therapeutics
RPTX
$74.7M
| $157K | ﹤0.01% |
12,979
-28,867
| -69% | -$349K |
|
3277
Alaunos Therapeutics
TCRT
$4.81M
| $157K | ﹤0.01% |
609
-93
| -13% | -$24K |
|
3278
Mustang Bio
MBIO
$10.5M
| $155K | ﹤0.01% |
441
-118
| -21% | -$41.5K |
|
3279
Cosan
CSAN
$2.49B
| $153K | ﹤0.01% |
+11,877
| New | +$153K |
|
3280
Vimeo
VMEO
$1.28B
| $151K | ﹤0.01% |
37,704
-10,030
| -21% | -$40.2K |
|
|
BCEL
3281
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $151K | ﹤0.01% |
96,209
+36,282
| +61% | +$56.9K |
|
|
BNR
3282
Burning Rock Biotech
BNR
$101M
| $149K | ﹤0.01% |
6,216
+3,450
| +125% | +$82.7K |
|
3283
Cytosorbents Corp
CTSO
$62.1M
| $149K | ﹤0.01% |
109,640
-75,989
| -41% | -$103K |
|
3284
Jerash Holdings
JRSH
$44.1M
| $149K | ﹤0.01% |
35,105
+6,582
| +23% | +$27.9K |
|
3285
Taitron Components
TAIT
$17M
| $148K | ﹤0.01% |
38,232
+4,668
| +14% | +$18.1K |
|
3286
Energy Services of America
ESOA
$174M
| $146K | ﹤0.01% |
50,923
+13,711
| +37% | +$39.3K |
|
3287
ACM Research
ACMR
$1.79B
| $145K | ﹤0.01% |
11,667
-209,895
| -95% | -$2.61M |
|
3288
Cullinan Oncology
CGEM
$392M
| $145K | ﹤0.01% |
+11,284
| New | +$145K |
|
3289
Dolphin Entertainment
DLPN
$13.9M
| $145K | ﹤0.01% |
27,272
-4,151
| -13% | -$22.1K |
|
|
DBTX
3290
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $143K | ﹤0.01% |
+41,341
| New | +$143K |
|
3291
Barnwell Industries
BRN
$11.3M
| $142K | ﹤0.01% |
53,704
| – | – |
|
3292
ADMA Biologics
ADMA
$3.83B
| $141K | ﹤0.01% |
58,179
-5,783
| -9% | -$14K |
|
|
LYLT
3293
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $138K | ﹤0.01% |
113,043
-180,045
| -61% | -$220K |
|
3294
Usio Inc
USIO
$38.9M
| $137K | ﹤0.01% |
106,076
-33,708
| -24% | -$43.5K |
|
3295
DURECT Corp
DRRX
$60.6M
| $136K | ﹤0.01% |
23,582
-2,742
| -10% | -$15.8K |
|
3296
Envela
ELA
$189M
| $136K | ﹤0.01% |
26,931
+12,200
| +83% | +$61.6K |
|
3297
Puma Biotechnology
PBYI
$228M
| $136K | ﹤0.01% |
+57,305
| New | +$136K |
|
3298
Shattuck Labs
STTK
$89.1M
| $136K | ﹤0.01% |
+50,434
| New | +$136K |
|
3299
enVVeno Medical
NVNO
$13.4M
| $135K | ﹤0.01% |
+21,489
| New | +$135K |
|
3300
Paysign
PAYS
$286M
| $135K | ﹤0.01% |
57,273
+14,934
| +35% | +$35.2K |
|